375 related articles for article (PubMed ID: 19815730)
1. Assessment of the integrin alpha5beta1 antagonist JSM6427 in proliferative vitreoretinopathy using in vitro assays and a rabbit model of retinal detachment.
Zahn G; Volk K; Lewis GP; Vossmeyer D; Stragies R; Heier JS; Daniel PE; Adamis AP; Chapin EA; Fisher SK; Holz FG; Löffler KU; Knolle J
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1028-35. PubMed ID: 19815730
[TBL] [Abstract][Full Text] [Related]
2. Effect of Robo1 on retinal pigment epithelial cells and experimental proliferative vitreoretinopathy.
Huang L; Xu Y; Yu W; Li Y; Chu L; Dong J; Li X
Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3193-204. PubMed ID: 20071679
[TBL] [Abstract][Full Text] [Related]
3. Targeting of integrin-linked kinase with a small interfering RNA suppresses progression of experimental proliferative vitreoretinopathy.
Guo L; Yu W; Li X; Zhao G; Liang J; He P; Wang K; Zhou P; Jiang Y; Zhao M
Exp Eye Res; 2008 Dec; 87(6):551-60. PubMed ID: 18926819
[TBL] [Abstract][Full Text] [Related]
4. Integrin alpha5beta1 mediates attachment, migration, and proliferation in human retinal pigment epithelium: relevance for proliferative retinal disease.
Li R; Maminishkis A; Zahn G; Vossmeyer D; Miller SS
Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5988-96. PubMed ID: 19608542
[TBL] [Abstract][Full Text] [Related]
5. Integrin-alpha5 mediates epidermal growth factor-induced retinal pigment epithelial cell proliferation and migration.
Chen Z; Chen CZ; Gong WR; Li JP; Xing YQ
Pathobiology; 2010; 77(2):88-95. PubMed ID: 20332668
[TBL] [Abstract][Full Text] [Related]
6. An alpha5beta1 integrin inhibitor attenuates glioma growth.
Färber K; Synowitz M; Zahn G; Vossmeyer D; Stragies R; van Rooijen N; Kettenmann H
Mol Cell Neurosci; 2008 Dec; 39(4):579-85. PubMed ID: 18804537
[TBL] [Abstract][Full Text] [Related]
7. siRNA targeting mammalian target of rapamycin (mTOR) attenuates experimental proliferative vitreoretinopathy.
Zhou P; Zhao MW; Li XX; Yu WZ; Bian ZM
Curr Eye Res; 2007 Nov; 32(11):973-84. PubMed ID: 18027173
[TBL] [Abstract][Full Text] [Related]
8. The effect of alkylphosphocholines on intraretinal proliferation initiated by experimental retinal detachment.
Eibl KH; Lewis GP; Betts K; Linberg KA; Gandorfer A; Kampik A; Fisher SK
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1305-11. PubMed ID: 17325177
[TBL] [Abstract][Full Text] [Related]
9. HGF regulation of RPE proliferation in an IL-1beta/retinal hole-induced rabbit model of PVR.
Liou GI; Pakalnis VA; Matragoon S; Samuel S; Behzadian MA; Baker J; Khalil IE; Roon P; Caldwell RB; Hunt RC; Marcus DM
Mol Vis; 2002 Dec; 8():494-501. PubMed ID: 12500176
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis and cell proliferation in proliferative retinal disorders: PCNA, Ki-67, caspase-3, and PARP expression.
Zhang X; Barile G; Chang S; Hays A; Pachydaki S; Schiff W; Sparrow J
Curr Eye Res; 2005 May; 30(5):395-403. PubMed ID: 16020270
[TBL] [Abstract][Full Text] [Related]
11. Active scatter factor (HGF/SF) in proliferative vitreoretinal disease.
Briggs MC; Grierson I; Hiscott P; Hunt JA
Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3085-94. PubMed ID: 10967068
[TBL] [Abstract][Full Text] [Related]
12. Proliferative vitreoretinopathy in the Swine-a new model.
Umazume K; Barak Y; McDonald K; Liu L; Kaplan HJ; Tamiya S
Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4910-6. PubMed ID: 22729438
[TBL] [Abstract][Full Text] [Related]
13. Muller cell reactivity and photoreceptor cell death are reduced after experimental retinal detachment using an inhibitor of the Akt/mTOR pathway.
Lewis GP; Chapin EA; Byun J; Luna G; Sherris D; Fisher SK
Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4429-35. PubMed ID: 19369237
[TBL] [Abstract][Full Text] [Related]
14. The small alpha5beta1 integrin antagonist, SJ749, reduces proliferation and clonogenicity of human astrocytoma cells.
Maglott A; Bartik P; Cosgun S; Klotz P; Rondé P; Fuhrmann G; Takeda K; Martin S; Dontenwill M
Cancer Res; 2006 Jun; 66(12):6002-7. PubMed ID: 16778170
[TBL] [Abstract][Full Text] [Related]
15. Preclinical evaluation of the novel small-molecule integrin alpha5beta1 inhibitor JSM6427 in monkey and rabbit models of choroidal neovascularization.
Zahn G; Vossmeyer D; Stragies R; Wills M; Wong CG; Löffler KU; Adamis AP; Knolle J
Arch Ophthalmol; 2009 Oct; 127(10):1329-35. PubMed ID: 19822850
[TBL] [Abstract][Full Text] [Related]
16. Immunoreactive ET-1 in the vitreous humor and epiretinal membranes of patients with proliferative vitreoretinopathy.
Roldán-Pallarés M; Rollín R; Mediero A; Martínez-Montero JC; Fernández-Cruz A; Bravo-Llata C; Fernández-Durango R
Mol Vis; 2005 Jul; 11():461-71. PubMed ID: 16030497
[TBL] [Abstract][Full Text] [Related]
17. Antisense oligonucleotide targeting c-fos mRNA limits retinal pigment epithelial cell proliferation: a key step in the progression of proliferative vitreoretinopathy.
Zhang L; Li X; Zhao M; He P; Yu W; Dong J; Liu G; Li C; Shi X
Exp Eye Res; 2006 Dec; 83(6):1405-11. PubMed ID: 16973160
[TBL] [Abstract][Full Text] [Related]
18. Retinoic acid in silicone and silicone-fluorosilicone copolymer oils in a rabbit model of proliferative vitreoretinopathy.
Nakagawa M; Refojo MF; Marin JF; Doi M; Tolentino FI
Invest Ophthalmol Vis Sci; 1995 Nov; 36(12):2388-95. PubMed ID: 7591628
[TBL] [Abstract][Full Text] [Related]
19. Modulation of hypoxia-induced neovascularization by JSM6427, an integrin alpha5beta1 inhibiting molecule.
Maier AK; Kociok N; Zahn G; Vossmeyer D; Stragies R; Muether PS; Joussen AM
Curr Eye Res; 2007 Sep; 32(9):801-12. PubMed ID: 17882713
[TBL] [Abstract][Full Text] [Related]
20. Ribozyme to proliferating cell nuclear antigen to treat proliferative vitreoretinopathy.
Mandava N; Blackburn P; Paul DB; Wilson MW; Read SB; Alspaugh E; Tritz R; Barber JR; Robbins JM; Kruse CA
Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3338-48. PubMed ID: 12356843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
